Trials / Completed
CompletedNCT05707403
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
Investigation of Pharmacokinetics and Absolute Oral Bioavailability of BI 1015550 Administered as an Oral Dose With an Intravenous Microtracer Dose of [14C]-BI 1015550 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This trial is intended to examine the absolute oral bioavailability of BI 1015550 as tablet formulation for oral administration, using an intravenous microtracer approach with \[14C\]-labelled BI 1015550. These data are considered necessary to further support the understanding of the pharmacokinetics of BI 1015550.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1015550 | Treatment T |
| DRUG | BI 1015550 mixed with [C-14]-BI 1015550 | Treatment R |
Timeline
- Start date
- 2023-02-14
- Primary completion
- 2023-03-28
- Completion
- 2023-03-28
- First posted
- 2023-01-31
- Last updated
- 2025-11-28
- Results posted
- 2025-11-28
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05707403. Inclusion in this directory is not an endorsement.